Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Amgen bids $167M to buy drug discovery shop Nuevolution

Il y a 5 jours
Amgen has offered $167 million to buy Nuevolution. The takeover will give Amgen control of a drug discovery platform that landed Nuevolution deals with leading companies plus a pipeline of early-stage...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Enemy or Valuable Ally? How Biotechs are Using Viruses for Good

Il y a 5 jours
Taking advantage of the viral world’s expertise in manipulating life is opening new doors for the biotech industry. Once only seen as our enemies, viruses are fast becoming some of our most valuable...
labiotech.eu
Une actualité de L'Usine Nouvelle a été ajouté(e)
Il y a 4 jours

Carmat va reprendre la production de ses coeurs artificiels pour les essais cliniques

Il y a 5 jours
Carmat a annoncé le 21 mai la reprise de la production de ses coeurs artificiels en vue d'essais cliniques. La PME française espère que les prochaines... - L'Usine Santé
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Google’s cancer-spotting AI outperforms radiologists in reading lung CT scans

Il y a 5 jours
Google’s artificial intelligence development has reached a milestone in lung cancer imaging and prediction, with a CT scan model being able to diagnose cases as well as or better than a group of six...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Novartis' asthma triplet beats GSK's Advair in phase 2 trial

Il y a 5 jours
Novartis’ triple combination asthma candidate QVM149 has beaten GlaxoSmithKline’s Advair in a phase 2 trial. The study linked QVM149 to statistically significant improvements in lung function, leading...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Find Your Partners In Crime in These Jobs!

Il y a 5 jours
Hello biotechnologists, Job hunt frustrating? Don’t worry, we’re here to help. Check out the exclusives offers from Twist Bioscience or become a DNA Synthesis Platform Team Leader at DNA Script. Just...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Spire Health launches COPD study with its machine-washable wearable

Il y a 5 jours
Using an innovative wearable, Spire Health has launched a study to develop new digital biomarkers that can predict exacerbations—and potentially hospitalizations—in patients with severe chronic...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Microbiome Companies Unite to Push for EU Regulation Reform

Il y a 5 jours
European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based treatments, which have the potential to treat inflammatory disease and...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Chugai ponies up $1B+ to combine R&D operations in Yokohama

Il y a 5 jours
Chugai Pharmaceuticals is shelling out ¥127.3 billion on a new R&D site in Yokohama, where it will combine the work of two long-standing research labs in nearby cities. It will start building the...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Evotec to acquire Gates Foundation-backed Just Biotherapeutics

Il y a 6 jours
Biotech-CRO hybrid Evotec is continuing its deals, buys and collabs strategy with its acquisition of U.S. biologics company Just Biotherapeutics....
www.fiercebiotech.com
Charger plus d'actualités